Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/12/2025 | 31/12/2024 |
|---|---|---|
| Revenue | — | 0 |
| Research and development | 52M | 38M |
| Selling, general and administrative | 17M | 12M |
| Operating expenses | 68M | 51M |
| Operating income | −68M | −51M |
| Pre-tax income | — | −42M |
| Income tax | — | 0 |
| Net income | −60M | −42M |
| Earnings per share | −2.17 | −2.18 |
| Earnings per share, diluted | −2.17 | −2.18 |
| Weighted average shares | 28M | 19M |
| Weighted average shares, diluted | 28M | 19M |
| Metric | 31/03/2026 | 31/12/2025 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 31/12/2024 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 20M | 76M | 43M | 21M | 22M | 22M | 41M | 77M |
| Short-term investments | 226M | 187M | 140M | 155M | 168M | 183M | 173M | 141M |
| Current assets | 253M | 268M | 185M | 177M | 192M | 206M | 215M | 220M |
| Property, plant and equipment | 1M | 830,000 | 880,000 | 856,000 | 891,000 | 989,000 | 888,000 | 801,000 |
| Total assets | 261M | 277M | 191M | 183M | 198M | 213M | 216M | 221M |
| Current liabilities | 7M | 10M | 6M | 7M | 9M | 10M | 6M | 4M |
| Total liabilities | 11M | 16M | 10M | 11M | 13M | 15M | 6M | 4M |
| Equity | 250M | 261M | 180M | 171M | 185M | 198M | 210M | 218M |
| Metric | 31/12/2025 | 31/12/2024 |
|---|---|---|
| Operating cash flow | −55M | −33M |
| Depreciation and amortisation | 323,000 | 258,000 |
| Share-based compensation | 10M | 7M |
| Capital expenditure | 231,000 | 514,000 |
| Investing cash flow | −4M | −70M |
| Financing cash flow | 113M | 109M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator